Five-Year Trends in Biomarker Testing and Targeted Therapy for NSCLC: A Patient-Initiated Nationwide Survey in Japan.
- DOI
- 10.1111/cas.70499
- Published
- 2026 Aug 7
- Container
- Cancer science
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/cas.70499,
title = {Five-Year Trends in Biomarker Testing and Targeted Therapy for NSCLC: A Patient-Initiated Nationwide Survey in Japan.},
author = {Ikeda S and Hasegawa K and Takahama T and Kachi K and Yanagisawa A and Kawakami S and Yoshida M and Sakai M and Watanabe S and Nakagawa K},
year = {2026},
journal = {Cancer science},
doi = {10.1111/cas.70499},
url = {https://doi.org/10.1111/cas.70499}
}RIS
TY - JOUR TI - Five-Year Trends in Biomarker Testing and Targeted Therapy for NSCLC: A Patient-Initiated Nationwide Survey in Japan. AU - Ikeda S AU - Hasegawa K AU - Takahama T AU - Kachi K AU - Yanagisawa A AU - Kawakami S AU - Yoshida M AU - Sakai M AU - Watanabe S AU - Nakagawa K PY - 2026 JO - Cancer science DO - 10.1111/cas.70499 UR - https://doi.org/10.1111/cas.70499 ER -
APA
S, I., K, H., T, T., K, K., A, Y., S, K., M, Y., M, S., S, W., & K, N. (2026). Five-Year Trends in Biomarker Testing and Targeted Therapy for NSCLC: A Patient-Initiated Nationwide Survey in Japan.. Cancer science. https://doi.org/10.1111/cas.70499
Source records
- pubmed · retrieved 2026-09-26T02:59:37.892Z
- europe-pmc · retrieved 2026-09-26T02:59:37.876Z